Browse studies

Find your next paid study

27,306 recruiting studies available now

Dynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium Contrast

Background: Cerebrospinal fluid (CSF) is the liquid that fills the space around the brain and spinal cord. Researchers do not fully understand how CSF flows a…

Healthy Volunteers

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Institute of Neurological Disorders and Stroke (NINDS)NCT07796360

Observational

Coaching and Leadership in Autism Support Settings

Schools serve a large number of autistic children, yet face two critical gaps that stifle the delivery of evidence-based practices: 1) an intervention gap char…

Autism Spectrum Disorder (ASD)

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, Los AngelesNCT07276750

Phase 2

Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial

The proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab …

Peanut Allergy

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT07015996

Phase 2

A Phase 2, Open-label, Fixed-dose Study to Assess the Efficacy of Sodium Phenylbutyrate (ACER-001) in Treating Pediatric and Adult Patients With Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Resulting From the Prevalent ACADM c.985 A>G (K304E) Mutation

This is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency…

Medium-chain Acyl-CoA Dehydrogenase Deficiency

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Jerry Vockley, MD, PhDNCT06773026

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that is uncontrolled by i…

Severe Asthma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Generate BiomedicinesNCT07276724

Phase 2

A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the…

Colitis, UlcerativeCrohn Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07483073

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Background: Researchers seek ways to study people s medical problems in order to teach and further general knowledge. The ability to assess and treat people w…

Wide Spectrum of DiseasesHematologic Diseases

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT04450927

Observational

Outcomes of a Digital Mindfulness Meditation App-Based Intervention in Adolescents With Moderate to Severe Atopic Dermatitis (MIND-AD)

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for interven…

Atopic DermatitisEczema

Estimated

~$10 – $750

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT07746427

Prospective Observational Multimodal Neuromonitoring in Adult Neurosciences Intensive Care Unit Patients: Characterization of Noninvasive Cerebral Autoregulation Indices, Quantitative EEG, and Physiologic Correlates Across NSICU Diagnoses

This is a prospective observational cohort study of adult patients admitted to the Neurosciences Intensive Care Unit (NSICU) at UT Southwestern Medical Center.…

Subarachnoid Hemorrhage, AneurysmalBrain Injuries, TraumaticCerebral Hemorrhage+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT07577713

Phase 1

A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

The purpose of this study is to understand the safety, tolerability, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy of orally a…

Acute Lymphoblastic LeukaemiaAcute Myeloid LeukaemiaHigher-risk Myelodysplastic Syndromes

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT07155226

Phase 1

Therapeutic RSK1 Targeting in Myeloid Malignancies

This study hypothesizes that PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), is safe and well tolerated in participants with myelofibrosis…

Myeloid Malignancy

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07379125

Longitudinal Neurocognitive Trajectories After BCMA CAR-T in Multiple Myeloma

The purpose of this research study is to evaluate cognitive changes over time in participants with relapsed or refractory multiple myeloma who have received ch…

Multiple Myeloma (MM)CART TherapyRefractory Multiple Myeloma (RRMM)

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07740317